Showing results (1801-1810 of 3,593) with videos related to
Sort By:
Pageof 360
Journal of Viral Hepatitis|June 9, 2012
The impact of fibrosis and steatosis on early viral kinetics in HCV genotype 1-infected patients treated with Peg-IFN-alfa-2a and ribavirinH Guedj, J Guedj, F Negro, et al.Journal of Viral Hepatitis|June 9, 2012
Maternal HBsAg status and infant size--a Faustian bargain?T T Lao, D S Sahota, S S H Suen, et al.Journal of Viral Hepatitis|January 15, 2016
The expanding toolbox for hepatitis C virus researchA M Ortega-Prieto, M DornerJournal of Viral Hepatitis|March 31, 2016
Wide variation in estimates of global prevalence and burden of chronic hepatitis B and C infection cited in published literatureS K Basnayake, P J EasterbrookJournal of Viral Hepatitis|February 12, 2016
A phase 3b study of sofosbuvir plus ribavirin in treatment-naive and treatment-experienced Korean patients chronically infected with genotype 2 hepatitis C virusS H Ahn, Y S Lim, K S Lee, et al.Journal of Viral Hepatitis|February 4, 2016
Disparate access to treatment regimens in chronic hepatitis C patients: data from the TRIO networkZ M Younossi, B R Bacon, D T Dieterich, et al.Journal of Viral Hepatitis|February 4, 2016
Achieving sustained virologic response after interferon-free hepatitis C virus treatment correlates with hepatic interferon gene expression changes independent of cirrhosisE G Meissner, A Kohli, K Virtaneva, et al.Journal of Viral Hepatitis|March 1, 2016
Potential market size and impact of hepatitis C treatment in low- and middle-income countriesM E Woode, M Abu-Zaineh, J Perriëns, et al.Journal of Viral Hepatitis|March 22, 2016
Direct costs of interferon-based and interferon-free direct-acting antiviral regimens for the treatment of chronic hepatitis C infectionE Gray, A O'Leary, J A Kieran, et al.Journal of Viral Hepatitis|April 10, 2016
Making the case for looking beyond WHO estimates for the global burden of hepatitis C and BH RazaviPageof 360